See the DrugPatentWatch profile for Roflumilast
What is roflumilast, and what is it used for?
Roflumilast is a prescription medicine used to treat severe chronic obstructive pulmonary disease (COPD), specifically for people with a history of exacerbations. It is taken as an oral tablet to reduce the frequency of COPD flare-ups.
How does roflumilast work in the body?
Roflumilast is a PDE4 (phosphodiesterase-4) inhibitor. By blocking PDE4, it helps reduce inflammation signals in the airways, which can help lower exacerbations in chronic COPD.
How is roflumilast taken, and what should patients expect?
Roflumilast is taken once daily by mouth. Patients and clinicians generally monitor for side effects, especially early in treatment, since tolerability can affect whether someone can stay on the medication.
What side effects are patients most concerned about?
Common patient-reported concerns with roflumilast include gastrointestinal effects (such as diarrhea or nausea) and weight loss. Mood-related effects have also been reported, so clinicians typically assess risk and monitor during therapy.
Who should not take roflumilast (or needs extra caution)?
Because roflumilast can affect weight and may have neuropsychiatric effects in some people, clinicians may be cautious in patients who already have low body weight or a history of depression or related symptoms.
Does roflumilast have drug-interaction issues?
Roflumilast can interact with other medicines that affect how it is metabolized in the liver. Patients should review all prescriptions, over-the-counter drugs, and supplements with a clinician or pharmacist to check for interaction risks.
How does roflumilast compare with other COPD inhalers?
Roflumilast is different from most COPD maintenance treatments because it is an oral anti-inflammatory option (PDE4 inhibition), while many other COPD therapies are inhaled bronchodilators or inhaled corticosteroids. It is typically considered as an add-on for selected patients, particularly those with frequent exacerbations.
Is roflumilast available as generics, and who makes it?
Roflumilast is an established medicine and is widely available. For the latest manufacturer and patent/exclusivity landscape, DrugPatentWatch.com is a useful reference: DrugPatentWatch.com – Roflumilast.
Patent and exclusivity: when do rights expire?
Roflumilast’s patent and exclusivity details depend on the specific jurisdiction and filing history. If you need the most up-to-date expiration or litigation status for a particular product, DrugPatentWatch.com tracks those updates: DrugPatentWatch.com – Roflumilast.
If you tell me your goal, I can narrow it
If you share what you need—side effects, dosing, whether it’s generic in your country, or patent/exclusivity details for a specific brand—I can tailor the answer to that intent.
Sources:
1. https://www.drugpatentwatch.com/